Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

Aethlon announces first patient enrolled and treated with the Hemopurifier at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital: San Diego Friday, January 31, 2025, 1 ...

An estimated 42 million people in India suffer from thyroid problems, an autoimmune condition that has grown very common. The most frequent cause is thought to be iodine deficiency brought on by ...

Professor Meghan Morrissey earns an innovation award to program immune cells to attack cancer tumors. #immunotherapy ...

Do you remember the fall of your high school senior year—the college essays, endless applications, forms, decisions, the big ...

The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...

The zodiac can predict football skills, with each sign bringing unique traits to the pitch. Aries is a fearless striker, ...

Hina Khan was all praises for her partner Rocky Jaiswal in a recent social media post. Jaiswal has been nursing her back to ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical ...